Ipsen Group - Company & Market Research Reports

Home /
Companies /
Ipsen Group

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 85
Central Nervous System Drugs 56
Endocrine and Metabolic Disorders Drugs 50
Drug Discovery 31
Musculoskeletal Disorders Drugs 26
Infusions and Injectables 25
Surgical Procedures 19
Pharmaceuticals 18
Biopharmaceuticals 15
Prostate Cancer Drugs 13
Drug Delivery 13
Clinical Trials 12
Women's Health 11
Dermatology 10
Pancreatic Cancer Drugs 10
Neurology 9
Liver Cancer Drugs 9
Oncology 9
Biotechnology 7
Healthcare Services 7
Lung Cancer Drugs 7
Medical Devices 7
Immune Disorders Drugs 6
Diagnostics 6
Gastrointestinal Drugs 6
Liver and Kidney Disorders Drugs 6
Sexual and Reproductive Health Drugs 6
Company Reports 5
Breast Cancer Drugs 5
Genomics 5
Thyroid Cancer Drugs 5
Urology and Nephrology 4
Ovarian Cancer Drugs 4
Brain Cancer Drugs 4
Enzymes 4
Over the Counter (OTC) Drugs 4
Dermatological Drugs 4
Therapeutic Area 3
Drugs by Therapeutic Area 3
Cardiovascular Drugs 3
Colon Cancer Drugs 3
Bladder Cancer Drugs 3
Managed Care 3
Kidney Cancer Drugs 3
Pediatrics 3
Gastroenterology 3
Optical Disorders Drugs 2
Lymphoma Drugs 2
In Vitro Diagnostics 2
Needles and Syringes 2
Hematology 2
Surgical Devices 2
Biosimilars and Biosuperiors 2
Nanomedicine 2
Urological Disorders Drugs 2
Pharmaceutical Intermediates 1
Allergy and Immunology 1
Infectious Diseases Drugs 1
Pharmacoeconomics 1
Leukemia Drugs 1
Cervical Cancer Drugs 1
Point-of-Care Diagnostics 1
Infectious Disease Testing 1
Analgesics 1
Healthcare 1
Transdermal and Transmucosal Drug Delivery 1
Hematological Drugs 1
Nuclear Medicine and Radiopharmacology 1
Skin Cancer Drugs 1
Other Healthcare Facilities 1
Laboratory Equipment 1
Anti-Obesity Drugs 1
Intensive Care and Emergency Medicine 1
Alzheimer's Disease Drugs 1
Pharmaceutical Manufacturing 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

442 Results (Page 14 of 23)
- Relevance
  Sort by

Europe Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

 Report
May 2023
82 Pages
Europe

From

€1319EUR$1,500USD£1,136GBP

LAMEA Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

 Report
May 2023
82 Pages
Africa, Middle East

From

€1319EUR$1,500USD£1,136GBP

North America Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

 Report
May 2023
72 Pages
North America

From

€1319EUR$1,500USD£1,136GBP

Asia Pacific Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

 Report
May 2023
83 Pages
Asia Pacific

From

€1319EUR$1,500USD£1,136GBP

Botulinum Toxin Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4351EUR$4,949USD£3,749GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Polycystic Kidney Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
July 2022
109 Pages
Global

From

€1758EUR$2,000USD£1,515GBP

Pancreatic Cancer Treatment Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3649EUR$4,150USD£3,144GBP

Atypical Teratoid Rhabdoid Tumours Treatment Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4351EUR$4,949USD£3,749GBP

Unresectable Hepatocellular Carcinoma Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3948EUR$4,490USD£3,402GBP

Colorectal Cancer Drugs Market Report 2025

 Report
March 2025
175 Pages
Global

From

€3948EUR$4,490USD£3,402GBP

Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) - Market Insight, Epidemiology and Market Forecast -2032

 Report
January 2022
224 Pages
Global

From

€6110EUR$6,950USD£5,265GBP

Dystonia Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration, By Type, By Regional Outlook and Forecast, 2022 - 2028

 Report
February 2023
200 Pages
Global

From

€3165EUR$3,600USD£2,727GBP

Pancreatic Cancer - Competitive Landscape, 2024

 Clinical Trials
December 2024
550 Pages
Global

From

€4396EUR$5,000USD£3,788GBP

Market Spotlight: Neuroendocrine tumors (NET)

 Report
May 2021
42 Pages
Global

€1159EUR$1,318USD£999GBP

Drugs for Benign Prostatic hypertrophy Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3948EUR$4,490USD£3,402GBP

Prostate Cancer Drugs Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3948EUR$4,490USD£3,402GBP

Keratoconjunctivitis sicca (Dry Eye) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
292 Pages
Global

From

€2198EUR$2,500USD£1,894GBP

HER2 Inhibitors Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3948EUR$4,490USD£3,402GBP

Contract Injectable Packaging Trends in the Bio/Pharma Industry

 Report
August 2022
96 Pages
Global

From

€4392EUR$4,995USD£3,784GBP

Locally Advanced Pancreatic Cancer Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

 Report
October 2023
190 Pages
Global

From

€3363EUR$3,825USD£2,898GBP

€3956EUR$4,500USD£3,409GBP

442 Results (Page 14 of 23)
- 1
- 12
- 13
- 14
- 15
- 16

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.